Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (Lancet, 2020)

(untitled) - Folegatti, PM; Ewer, KJ; Aley, PK; Angus, B; Becker, S; Belij-Rammerstorfer, S; Bellamy, D; Bibi, S; Bittaye, M; Clutterbuck, EA; Dold, C; Faust, SN; et al.